Literature DB >> 5560501

Protamine sulfate administration and the cardiovascular system.

A Gourin, R L Streisand, J K Greineder, J H Stuckey.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5560501

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  6 in total

1.  Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass.

Authors:  Alejandro Aris; Heriberto Solanes; Jose O. Bonnin; Rosa Garin; Jose M. Caralps
Journal:  Cardiovasc Dis       Date:  1981-03

2.  Cardiovascular depressant effect of protamine sulphate: experimental study and clinical implications.

Authors:  M A Fadali; C A Papacostas; J J Duke; M Ledbetter; M Osbakken
Journal:  Thorax       Date:  1976-06       Impact factor: 9.139

3.  Mechanism responsible for the cardiovascular depressant. Effect of protamine sulfate.

Authors:  M A Fadali; M Ledbetter; C A Papacostas; L J Duke; G M Lemole
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

4.  Impaired myocardial function and oxygen utilization due to protamine sulfate in an isolated rabbit heart preparation.

Authors:  T W Wakefield; L E Bies; S K Wrobleski; S F Bolling; J C Stanley; M M Kirsh
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

5.  Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs.

Authors:  R K Stoelting; D P Henry; K M Verburg; R L McCammon; R D King; J W Brown
Journal:  Can Anaesth Soc J       Date:  1984-09

6.  Use of activated clotting time for monitoring anticoagulation during cardiopulmonary bypass in infants and children with congenital heart disease.

Authors:  S Bert Litwin; Samir K. Mitra; Rochelle Von Colditz; John Von Colditz; Linda B. Hamilton; Terrance McManus; Hani G. Jume'an; Jack Lazerson
Journal:  Cardiovasc Dis       Date:  1981-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.